RDNT Competitors & Alternatives
Compare RadNet Inc with similar stocks in the same industry
Diagnostics & Research
RDNT
Main Stock$76.91
Tradestie Score
37
Market Cap
$6.00B
Revenue Growth
0.3%
Analyst Upside
+20.8%
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRL
Charles River Laboratories International, Inc.
|
$292.48
|
$8.39B | - | 34 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$167.42
|
$7.81B | - | 43 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$19.19
|
$4.60B | 33.1 | 47 | Compare |
|
BLLN
BLLN
|
$95.44
|
$4.33B | 123.9 | 68 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$100.29
|
$3.51B | 24.0 | 54 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$83.34
|
$3.26B | - | 35 | Compare |
|
VCYT
Veracyte, Inc.
|
$41.69
|
$2.85B | 30.1 | 60 | Compare |
|
SGRY
Surgery Partners, Inc. Common Stock
|
$13.92
|
$2.72B | - | 44 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$77.41
|
$2.24B | - | 40 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.45
|
$2.22B | - | 44 | Compare |
More RDNT Analysis
Data updated: Aug 21, 2026 | Industry: Diagnostics & Research (SIC 8071)
38 stocks in this industry